|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
1999-10-13
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0091-6765
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
107
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
A395
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:10441320-Aryldialkylphosphatase,
pubmed-meshheading:10441320-Epidemiologic Methods,
pubmed-meshheading:10441320-Esterases,
pubmed-meshheading:10441320-Fatigue Syndrome, Chronic,
pubmed-meshheading:10441320-Fibromyalgia,
pubmed-meshheading:10441320-Humans,
pubmed-meshheading:10441320-Multiple Chemical Sensitivity,
pubmed-meshheading:10441320-Polymorphism, Genetic,
pubmed-meshheading:10441320-Research Design
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Paraoxonase/MCS.
|
|
pubmed:publicationType |
Letter
|
